These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11482741)

  • 1. Can drugs or micronutrients prevent cataract?
    Harding JJ
    Drugs Aging; 2001; 18(7):473-86. PubMed ID: 11482741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in pharmacological strategies for the prevention of cataract development.
    Gupta SK; Selvan VK; Agrawal SS; Saxena R
    Indian J Ophthalmol; 2009; 57(3):175-83. PubMed ID: 19384010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological prevention of diabetic cataract.
    Kyselova Z; Stefek M; Bauer V
    J Diabetes Complications; 2004; 18(2):129-40. PubMed ID: 15120709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment strategies in age-related cataracts.
    Harding JJ
    Drugs Aging; 1992; 2(4):287-300. PubMed ID: 1504443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can cataract be prevented?
    Harding JJ
    Eye (Lond); 1999 Jun; 13 ( Pt 3b)():454-6. PubMed ID: 10627824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cataract prevention. Therapeutic approaches and critical review of current status].
    Wegener A
    Ophthalmologe; 2003 Mar; 100(3):176-80. PubMed ID: 12640545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antioxidant micronutrients and cataract. Review and comparison of the AREDS and REACT cataract studies].
    Schalch W; Chylack LT
    Ophthalmologe; 2003 Mar; 100(3):181-9. PubMed ID: 12640546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay or inhibition of rat lens opacification using pantethine and WR-77913.
    Clark JI; Livesey JC; Steele JE
    Exp Eye Res; 1996 Jan; 62(1):75-84. PubMed ID: 8674515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy in the prevention of cataract.
    Brown NA; Bron AJ
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantethine. Monograph.
    Altern Med Rev; 2010 Sep; 15(3):279-82. PubMed ID: 21155629
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of lens opacification during the early stages of cataract formation.
    Hiraoka T; Clark JI
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2550-5. PubMed ID: 7591646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current medical aspects of pantethine.
    Horváth Z; Vécsei L
    Ideggyogy Sz; 2009 Jul; 62(7-8):220-9. PubMed ID: 19685700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of nutrition in the prevention of ocular disease with special reference to cataract.
    Agte V; Tarwadi K
    Ophthalmic Res; 2010; 44(3):166-72. PubMed ID: 20829640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selected anti-cataract agents on opacification in the selenite cataract model.
    Hiraoka T; Clark JI; LI XY; Thurston GM
    Exp Eye Res; 1996 Jan; 62(1):11-9. PubMed ID: 8674506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pantethine and ultraviolet-B radiation on the development of lenticular opacity in the emory mouse.
    Congdon NT; West ST; Duncan DT; Fisher DT; Vitale ST; Rieger KT; Urist JT; Hazelwood DT; Sanchez AT; Pham T; Cole L; McNaughton C
    Curr Eye Res; 2000 Jan; 20(1):17-24. PubMed ID: 10611711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):221-3. PubMed ID: 2697544
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
    Ohrloff C; Hockwin O; Korte I; Wegener A
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.
    Sahoo PK; Behera P
    Eur J Med Chem; 2010 Mar; 45(3):909-14. PubMed ID: 19962793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the prevention of side-effects by antituberculous drugs with special reference to effectiveness of pantethine (author's transl)].
    Aoyagi T; Yamada Y; Kaneko K; Aizawa Y; Nanba A; Watabiki S; Kakazu Y; Hasegawa T; Fukuhara Y; Matumiya T; Komoriya T; Yoshida F; Kawamoto H; Ozawa R; Nishiyama K; Takahashi S; Nukada H; Kawame S; Fujita S; Oosato T; Murata A; Ishihara M; Kita R; Yoshitake H; Honda A; Hashimoto S; Kida E
    Kekkaku; 1977 Nov; 52(11):563-8. PubMed ID: 599776
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.